Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1973 4
1974 2
1975 2
1976 5
1977 2
1978 4
1979 3
1980 9
1981 11
1982 6
1983 17
1984 11
1985 16
1986 9
1987 8
1988 14
1989 20
1990 32
1991 34
1992 25
1993 19
1994 17
1995 23
1996 25
1997 42
1998 15
1999 8
2000 5
2001 1
2002 3
2003 1
2004 2
2005 2
2006 4
2007 2
2008 2
2009 1
2010 3
2011 3
2012 2
2013 1
2014 1
2017 2
2018 2
2020 1
2021 2
2022 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trümper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Pfreundschuh M, et al. Among authors: mertelsmann r. Lancet Oncol. 2008 Feb;9(2):105-16. doi: 10.1016/S1470-2045(08)70002-0. Epub 2008 Jan 15. Lancet Oncol. 2008. PMID: 18226581 Clinical Trial.
[Tumor necrosis factor].
Herrmann F, Mertelsmann R. Herrmann F, et al. Among authors: mertelsmann r. Dtsch Med Wochenschr. 1989 Feb 24;114(8):312-6. doi: 10.1055/s-0029-1235647. Dtsch Med Wochenschr. 1989. PMID: 2646094 Review. German. No abstract available.
Hematopoietic stem cell transplantation: more than just hematopoietic?
Spyridonidis A, Mertelsmann R, Finke J. Spyridonidis A, et al. Among authors: mertelsmann r. J Cancer Res Clin Oncol. 2004 Mar;130(3):127-34. doi: 10.1007/s00432-003-0507-x. Epub 2004 Jan 16. J Cancer Res Clin Oncol. 2004. PMID: 14727105 Free PMC article. Review.
Interleukin-3 and its receptor.
Lindemann A, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. Cancer Treat Res. 1995;80:107-42. doi: 10.1007/978-1-4613-1241-3_5. Cancer Treat Res. 1995. PMID: 8821576 Review. No abstract available.
Interleukin-3: structure and function.
Lindemann A, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. Cancer Invest. 1993;11(5):609-23. doi: 10.3109/07357909309011680. Cancer Invest. 1993. PMID: 8402229 Review. No abstract available.
Hemopoietins in clinical oncology.
Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R. Kanz L, et al. Among authors: mertelsmann r. Am J Clin Oncol. 1991;14 Suppl 1:S27-33. doi: 10.1097/00000421-199112001-00006. Am J Clin Oncol. 1991. PMID: 2048561 Review.
The epitope recognized by rituximab.
Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M. Binder M, et al. Among authors: mertelsmann r. Blood. 2006 Sep 15;108(6):1975-8. doi: 10.1182/blood-2006-04-014639. Epub 2006 May 16. Blood. 2006. PMID: 16705086 Free article.
428 results